New eye drops show promise for dry eye sufferers
NCT ID NCT06792903
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-phase trial tested YM-101 eye drops in 30 adults with dry eye syndrome. Participants received either high or low dose YM-101 plus artificial tears, then switched to placebo after a washout period. The study measured changes in corneal staining, tear break-up time, and symptom scores to see if the drops improve eye surface health and comfort.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- YM-101 eye drops
- What this could lead to
- If successful, this could point toward a new treatment option for dry eye syndrome, easing discomfort and improving eye surface health.
- What could go wrong
- This is a very early, small trial with only 30 people. The results may not apply to everyone, and the treatment might not work better than a placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Eye & ENT hospital of Fudan University
Shanghai, Shanghai Municipality, 20031, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can insulin eye drops quench dry eyes?
- Can a new eye drop soothe severe dry eye?
- New imaging tools put to the test for measuring dry eye treatment effects
- Could a special screen light reduce tired eyes and dryness?
- Nasal spray could make contact lenses more comfortable
- Dry eye drops may sharpen cataract surgery outcomes